干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
中源协和

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 41384|回复: 0
go

干细胞移植常用生物学词汇 [复制链接]

Rank: 1

积分
威望
3  
包包
20  
楼主
发表于 2008-12-27 14:20 |只看该作者 |倒序浏览 |打印
2,3-DPG:2,3-diphosphatidylglyceric acid,2,3-二磷酸甘油酸% z* [# U4 r% @# |4 q
2-CdA:2-chlorodeoxyadenosin,cladribine,2-氯去氧腺苷
" q- M, y/ [  H% a  i8 a% Q) p3H-TdR:tritiated thymide,氚标记胸腺嘧啶核苷3 N1 F* I% c& b, I8 k
5-Aza:5-azacytidine,5-氮(杂)胞苷
6 u# c0 [- F5 D  t" d! }# [: |a2-PI:a2-antiplasmin, a2-纤溶酶原抑制物
$ l+ H4 [) j/ f4 R7 D4 aAA:aplastic anemia,再生障碍性贫血4 h$ P2 X- d! D
AAV:adeno-associated virus,腺病毒相关病毒
+ u; \* T) z+ m2 `' {/ ?  SAb:antibody,抗体* s: k6 ^9 a2 F0 e
ABC:avidin-biiotin complex method, 亲和素生物素复合物法
& T( K6 L/ b: j) r. GABMT:autologous bone marrow transplant,自体骨髓移植2 a6 S: N; G' d/ R
Ac:accessory cell,辅佐细胞
* ?0 a3 Y! n6 T' ~9 B) AACD:acid citrate dextrose,酸性枸橼酸盐葡萄糖. n! K. w1 t0 P/ _' @3 U! {
ACP:acid phosphatase,酸性磷酸梅. W1 N, G$ ~, H5 ?. b( k
ACTD:actinomycin D,放线菌素D
3 l( l8 h! `% t: J8 p3 z% vAcute:急性的 / {& ~. D. g3 S
ACV:cyclovir,阿昔洛韦9 \- D9 F$ h* f# K
Ad:adenovirus,腺病毒
/ ]! n8 \8 ?. H- H( qAD:antigen determinant,抗原决定簇, E2 c" u9 t  o* N  t- s
ADA:adenosine deaminase,腺苷脱氨酶
- f. }' Y; J4 [5 `ADCC:antibody-dependent cell-mediated cytotoxicity)抗体依赖细胞介导性细胞毒性+ h  s8 |. [" H& e, e- Y  J5 f
Adjuvant therapy:辅助治疗
" E8 Z; L% L8 y5 cAEL:acute erythrocytic leukemia,急性红白血病
1 k& z9 m0 X1 w/ L: xAEoL:acute eosinophilic leukemia,急性嗜酸粒细胞白血病1 }4 N; U  G7 B+ J. @# ?1 C
AFP:alpha fetoprotein,甲胎蛋白+ x* ?$ _( D% y, n* ^) a: e
Ag:antigen,抗原
! y, o7 u- k; C( ?7 b/ DaGVHD:acute graft versus host disease,急性移植物抗宿主病
+ a# |0 n/ A5 g: D0 x" V* \Aid:anti-idiotype antibody,抗独特型抗体  A. o& v% s' Z! a; b- B
AidS:acquired immune deficiency syndrome,获得性免疫缺陷综合征
* L. O: c$ J" [; hAIF:apoptosis-inducing factor,凋亡诱导因子
' a" p) b. V% FAIHA:autoimmune hemolytic anemia,自身免疫性溶血性贫血
: |7 R7 g1 s- x% o  cAL:acute leukemia, 急性白血病
6 _6 p+ a+ ]" Q( V' Q* e; k) B" QALCL:anaplastic large cell lymphoma,退行性大细胞淋巴瘤
" F/ _& Z( v# J: LALG:antilymphocyte globulin, 抗淋巴细胞球蛋白
/ d  o7 W) W4 E, cALIP:abnormal localization of immature precursor,未成熟前体细胞异常定位+ F$ d$ F* r) A* a: ^" w4 q
ALL:acute lymphocytic leukemia,急性淋巴细胞白血病! z* t/ |+ G0 O  d
Allo-BMT:allogeneic bone marrow transplantation,异基因骨髓移植/ I5 L5 I8 `; c; O
Allo-PBSCT:allogeneic peripheral blood stem cell transplantation,异基因外周血干细胞移植% A6 y7 Y: K' v+ P9 F
Allogeneic:异基因的
8 A! Q$ V2 L; Y) ?Allograft:异体移植物
2 i, {6 R( g( k+ ?; e' }1 {Alopecia:脱发& {3 l8 D, T( p7 I
ALP(AKP):Alkaline phosphatase,碱性磷酸酶
6 _1 p" h) ^+ \$ H  L3 D) @3 UAM:adhesion molecule,粘附分子
' m, a9 o) k6 O- f2 n- fAMKL:acute megakaryoblastic leukemia,急性巨核细胞白血病" Z* N4 p! u, [2 O2 ~! j. ^
AML:acute myeloid leukemia,急性髓性白血病$ U& {. _( Z0 ]. _* T2 h6 F
AMM:agnogenic myeloid metaplasia,特发性髓外化生
: N- v. U7 n8 N. ^ANA:antinuclear antibody,抗核抗体
# l. m- C' F; t% F3 h% y. iAna-LL:anaplastic large cell lymphoma,大细胞淋巴瘤2 {: t( i" I' f" C4 U( |
Anaphylaxis:过敏症1 d* I7 z7 r& v. l

) q2 |: K" n; e# q6 GANC:absolute neutrophil count,中性粒细胞绝对值
- k: @; p5 o9 t. B& ^& X/ rAnemia:贫血
  U; j  S, u( ]; c0 GANLL:acute non-lymphocytic leukemia,急性非淋巴细胞性白血病
2 c0 Z7 R6 }- \Antibiotic:抗生素;抗生的 . v) f) T& h7 R/ V% t2 F
Antiemetic:止吐剂,止吐药
( L+ ]: v1 e/ K" N/ ?+ P* zantineoplastic drugs:抗肿瘤药物) \) J9 M9 W0 \6 w/ R1 p$ ^
Antisense:反义引物
) Z/ e% D( f# }( z" R0 W4 B2 _% XAPBSCT:autologous peripheral blood stem cell transplantation,自体外周血干细胞移植
; |8 e. @& n* K+ e6 H: M  }, BAPC:antigen processing cell,抗原呈递细胞
" z2 E* J- G. Z7 Q1 A+ I5 BApheresis:血浆分离置换法,血液成分部分清除
2 k% i) a7 a! F" K: F1 R) hAPL:acute promyelocytic leukemia,急性早幼粒细胞白血病
5 y3 w( f. O* t1 J$ f3 VAplasia:发育不良,成形不完全 " N/ p7 [+ h7 @
Apoptosis:凋亡
8 B# D3 v8 W& Y' ?+ W, U) FAra-C:arabinosyl cytosine,aracytidine阿糖胞苷
3 a8 G5 V9 d. NARDS:acute respiratory distress syndrome,急性呼吸窘迫综合症;AidS-related diseases艾滋病相关疾病
9 r2 Z6 ?( \' a7 K, X" E& I7 Q+ GAscites:腹水
( E4 a' ~* w# @% _  iASCT:autologous stem cell transplantation,自体干细胞移植
7 V. D0 u+ t2 r% K! A* o/ C  oAspergillus:曲霉属0 C- h) m1 j& J8 I& U* b5 a
ASS:anterior superior spine,髂前上棘
5 A& ]7 A# s9 e3 \; \* ZAT1257:nitrocaphane,消瘤芥
3 y$ m( g, S' _- [% t3 g& RATG:antithymocyte globulin,抗胸腺细胞球蛋白% T2 q8 L7 n6 w% e
ATL:adult T cell leukemia/lymphoma,成人T细胞白血病/淋巴瘤$ Q0 Q4 x! `( k% R/ O$ R) ?/ l/ \- j& n
ATLS:acute tumor lysis syndrome,急性肿瘤溶解综合征) J, I9 l) h# Q0 A
ATRA:all-transretinoic acid,全反式维甲酸
" w% ^! ^: c9 H3 Y  BAUL:acute undifferentiated cell leukemia,急性未分化细胞白血病% Z8 }+ g- y% [2 R9 h# x
AuSCT: autologous stem cell transplantation,自体造血干细胞移植3 @* E/ X1 u) b0 v
Autologous:自体的 3 ^2 V0 ]# p! [/ \) _% u; Y
Autograft:自体移植物 ( S8 d% V! V- [7 k5 x
Auto-BMT: autologous bone marrow transplantation,自体骨髓移植' g4 Y* J# ]0 D
β2-MG:β2-microglobulin,β2-微球蛋白
1 q) Z* v9 f& `% W; C* A) iBack-up:备份
; N' j  Z& w( FBCNU:Carmustine,卡氮芥,卡莫司汀
+ Z7 `5 w5 s8 S6 ~$ E; h) |/ e: WBCR:breakpoint cluster region,断裂点丛集区8 Y0 B  m+ v! s2 M. O7 M
BFU-E: burst-forming unit-erythroid,早期红系集落生成细胞# v8 ~/ c" [9 N- x
Biopsy:活检 % `6 q% x" T4 F( Z, B
Blast cell:原始血细胞,母细胞
0 Z3 u+ Q. R0 QBlast-CFC:blast colony forming cell,原始细胞集落形成细胞
" u  ?  j/ P( U8 S  L! }Blast crisis:原始细胞危象
1 Q% D: X$ a$ a6 }6 OBm:memory B lymphocyte,记忆B淋巴细胞
9 L" f1 o: h4 w4 L* _BMG:benign monoclonal gammopathies,良性单克隆丙球蛋白病! C+ _7 j: g7 e- t0 l4 q0 F
BMT:bone marrow transplantation,骨髓移植
0 m- `9 [& ~# wBone marrow biopsy:骨髓活检& ?7 c$ u% E; J
Bone marrow puncture:骨髓穿刺
# W/ \7 F* n" Y+ {" PBone marrow smear:骨髓穿刺涂片6 e5 X/ L) e) v" k8 r. `1 @
BRM:biological response modifier,生物应答调节剂
/ O7 |4 ^) N  o, n# [! jBu:busulfan,白消安,马利兰
' ~7 i0 m: j0 Y) _Buffer:缓冲,缓冲剂,缓冲液$ z, y6 m7 O5 L9 o9 W# M: x1 c, Q
CALLA:common acute lymphocytic leukemia antigen,普通急性淋巴细胞白血病抗原8 C& X' J& S4 ^5 H
CAM:cell adhesion molecule,细胞粘附分子
# C# \. l7 G4 k$ eCandida:念珠菌属,假丝酵母属
9 W2 n4 {2 a. o' g* @, z$ v" LCatheter:导管
0 R1 v2 ?# e/ y) s* ?CB:cord blood,脐带血
) P: D6 J: W4 ICB1348:chlorambucil:苯丁酸氮芥
: |8 [5 Q5 e; _7 C+ P, |) QCBC:complete blood count,全血细胞计数 ) m* Y- T+ T: @7 e/ m0 K
CBCL:cutaneous B-cell lymphoma,皮肤B细胞淋巴瘤
  g. Y" u) {+ Q1 {! _( F3 h8 \9 VCBSCT:cord blood stem cell transplantation,脐血干细胞移植
( E4 P' Z' {4 Q5 \" ]% Z" f" S# jCCI:corrected count increment,校正增值计数2 @0 Q3 `8 e' U; H/ b- U- M$ ~
CCNSA:cell cycle non-specific agents,细胞周期非特异性药物
; `& R# g! c* |) B6 p( n, xCCNU:lomustine,洛莫司汀,环己亚硝脲8 \0 |* h% d: _, x
CCR:continuous complete remission,持续完全缓解
) S4 G% t- W8 n* q/ eCCSA:cell cycle specific agents,细胞周期特异性药物
& z* N# I: C' l0 SCD:Castleman's disease,Castleman病
4 i* v& q) N/ G! D/ A# N7 y" j% vCD:cluster of differentiation,分化群
; s. M. y& |4 E9 e- aCD3AK:CD3 activated killer,CD3激活的杀伤细胞& y) j3 Z; N( _( S; q
CDK:cyclin dependent protein kinase,周期素依赖蛋白激酶+ t5 c9 z9 T% V. s
CEA:carcinoembryonic antigen,癌胚抗原( q* p1 D3 Q7 o9 E& C
CEL:chronic eosinophil leukemia,慢性嗜酸性粒细胞白血病
7 J/ y3 q; v* a+ d6 X2 T0 bCentral line:中心静脉导管,见central venous catheter.
' E, S* P8 {5 M3 f% C* V5 ?Central venous catheter: 中心静脉导管,又叫做central line,Hickman catheter 4 B6 n3 ~/ h% _+ D7 y9 P' D: k- O6 H
Centrifugation:离心) v8 x1 h$ X: f+ }5 B1 }% G% F2 `+ _
CFC:colony-forming cell,克隆形成细胞
6 U, u9 m( p* R7 \+ rCFU:colony-forming unit,集落形成单位
* _* i. t/ R0 h- A; |' f8 C7 W1 BCFU-Blast:colony-forming unit-Blast,原始集落生成细胞$ N: C2 ?) a; S4 f4 T8 V
CFU-E:colony-forming unit-erythroid,红系集落生成细胞$ X6 R9 m/ x& D
CFU-G:colony-forming unit-granulocyte,粒系集落生成细胞
6 A% L' j) u+ [( @* HCFU-GM:colony-forming unit-granulocyte/macrophage,粒单系集落生成细胞: Y2 R5 x+ W# ]8 x
CFU-L:colony-forming unit-leukemia,白血病细胞集落生成单位
, X3 T# D% p$ j8 v# u! a+ `CFU-MEG:colony-forming unit-megakaryocyte巨核系集落生成细胞
. N9 R& q" g* h9 u3 G! sCGD:chronic granulomatous disease,慢性肉芽肿病
' m) H. q6 M/ jCGP:circulating granulocyte pool,循环粒细胞池% ?; K4 z- f  j
cGVHD:chronic graft versus host disease,慢性移植物抗宿主病# W. ~* T0 C2 v7 U  k9 Q
Chemo-responsive:化疗敏感的 " p  ^( M$ H7 ~& f/ l
Chemotherapy:化学疗法
  e" t4 Z7 r! Z- K7 E7 UChronic慢性的
. j& [7 s% u! L/ ^+ ^$ nC.I.:continuous infusion,持续静脉点滴
  p+ R2 X: ?- }CIK:cytokine-induced killer cells 细胞因子诱导的杀伤细胞+ ]/ \* _0 z. ?; ~6 c; ^2 X; o
CliniMACS:clinical magnetic activated cell sorting,临床级磁性活化细胞分选系统$ y* x: ?* d, L/ L: B  z9 @
CLL:chronic lymphocytic leukemia,慢性淋巴细胞白血病
- {9 H, S0 b3 i9 B0 y/ tCML:chronic myelogenous leukemia,慢性粒细胞白血病
1 p+ o7 e8 s! U1 ~3 {" Y" JCML-AP:CML-accelerated phase,慢性粒细胞白血病加速期
$ [6 r# p  z* H2 Z! j4 A3 RCML-BP:CML-blastic phase,慢性粒细胞白血病急变期( {, _) x8 i; Q" P
CML-CP:CML-chronic phase,慢性粒细胞白血病慢性期
/ }9 y' h6 |7 U! Z7 LCMML:chronic myelo-monocytic leukemia,慢性粒-单细胞白血病4 z2 F8 E% }5 \8 O2 m
CMPD:chronic myeloproliferative disease,慢性骨髓增生性疾病
0 ~; d0 j' H2 C" K; U1 }, rCMV:cytomegalovirus,巨细胞病毒1 R, n* Z  \6 z; G3 j- k2 p7 k
CNR:cytokine negative response cell,细胞因子不反应细胞
# W' N5 m! i* gCNS:central nervous system,中枢神经系统
1 T& O; T9 [, }  M, g2 PCNSL:central nervous system leukemia,中枢神经系统白血病% t! L) ~4 |; @+ m: v2 W
Collection: 采集( T( q4 r1 d4 h2 V& f
Colony stimulating factor:集落刺激因子 8 y$ E* ]7 |4 N; C
c-onc:cellular oncogene,细胞癌基因
, M: E, o9 {$ LConditioning:预处理 " ~3 ]" D: g. l" {' ]
Conjunctivitis:结膜炎9 D+ g5 H1 Q7 D- P
Convalescence:恢复,恢复期8 h& _9 t- i! b& G
CP:cancer procoagulant,癌性促凝物质
/ V$ E& w# E2 F  r* B5 QCPD:citrate phosphate dextrose,枸橼酸盐-磷酸盐-葡萄糖5 G1 q! E4 \) _
CPDA: citrate phosphate dextrose adenine,枸橼酸盐-磷酸盐-葡萄糖-腺嘌呤4 a0 B9 h% P" J8 N+ f
Cpmax:peak concentration,峰浓度) Z. C: k9 u5 H
CPT:camptothecine,喜树碱
- L9 N9 D. j. Q+ iCR:complete remission,完全缓解' l1 x; ^* N9 g" ?/ X$ u& o
CRABP:cytoplasmic retinoic acid binding protein,胞浆维甲酸结合蛋白
5 o+ r: |1 ]; R- p: |+ GCRP:C reaction protein,丙反应蛋白 ( n8 @% ~" n, k, ^+ r. l3 }. H
CRR:complete remission rate,完全缓解率
6 j& x4 ?+ ?0 B& o1 D) XCryopreservation:冷冻保存,深低温保藏 + b  W' h; ~+ d# M, P2 J9 e
CSF:colony stimulating factor,集落刺激因子! [! j9 J6 K6 ^% N2 X" Z! i  f
CSF:cerebrospinal fluid,脑脊液5 r9 x8 H- \0 H' p( v% A2 ^1 u
CTCL:cutaneous T cell lymphoma,皮肤T细胞淋巴瘤) F* X+ j* C- U7 ~+ a
CTCL:central T cell lymphoma,中枢T细胞淋巴瘤3 g; Y! }: I4 Z4 N  F! V/ H
CTL:cytotoxicity T lymphocyte,细胞毒性T淋巴细胞. e6 F* Z4 Z( R8 I4 u! o- U0 W
Cyclin:周期素
4 I9 H9 h* c9 E4 }3 iCytomegalovirus:巨细胞病毒   M5 X( F  E9 y0 p) r; n" x( U
DC:dendric cell,树突细胞: [" a& [8 f: X" {" K* b
D-D:D dimer,D-二聚体
1 n. ?& s5 V( a6 \& |! S; R+ B0 ]0 _Del:deletion,缺失$ s  j1 B8 Q0 z5 s$ z+ o& {
Dermatitis:皮炎
' S4 J* r2 @( B1 D# ~3 EDe nova AML:非继发性急性髓性白血病 2 H) t& H! A/ J5 U% ]0 X
DFS:disease free survival,无病生存期5 |% {3 u% ^5 S- i
DI:DNA index,DNA 指数' V# x) V" V& u" ~+ E
DIC:disseminated intravascular coagulation,播散性血管内凝血( M, W! o* C$ S3 _
Dilution:稀释9 i% p+ j$ O+ `. u! y, g
DL:discordant lymphoma,混杂型淋巴瘤
3 A# e0 |4 d- K+ J& a3 ]/ s0 UDonor:供者
; c% @4 K/ M9 r8 t; eDysplasia:发育不良,发育异常
; `4 F0 Y- ?( D. PEBV:Epstein-Barr virus,EB病毒" w/ E8 b( {: X  N
ECM:extracellular matrix,细胞外基质, T( d$ Z- U3 M) e1 ?) `: _
-ectomy:(后缀)(外科)切除,除去,去掉 - o/ F3 q* d& {3 M5 |
Edema:水肿 5 e4 o( ?9 {: W
EGF:epithelial growth factor,表皮生长因子
8 X1 f* \  B7 k5 K, W-emia:(后缀)血液疾病
( Y3 O& p1 @; i$ L' tEncephalopathy:脑病
6 ?$ P) J; [7 u7 f5 QEncode: 编码
- \3 Z& t$ p+ a' @. hEngraftment:移植物植入 " e: G: a" c3 X" o$ x
Enrich:富集) t2 J& j+ }3 _' ?- _  r% T
Enzyme:酶 ' L" D# q, _( d; @+ F
Eosinophil:嗜酸性粒细胞
9 c+ z2 j) X% |+ C. B% g/ U  UEPO:erythropoietin,促红素,红细胞生成素( F- n1 e: t. z
ETT:essential thrombocythemia,原发性血小板增多症
( \! v9 C$ V: JEx vivo:体外
' r) z2 _6 F+ SFACS:fluorescence activated cell sorting,荧光活化细胞分选系统; P# a, i. H2 l. q! i
FCM:flow cytometry,流式细胞分析技术! T5 W3 F/ P6 j% g; R
FDC:follicular dendritic cells,滤泡树突状细胞7 f& |& Q: M4 u
FDGF:fibroblast derived growth factor,成纤维细胞源生长因子 5 N/ p. U. N4 S0 a8 K5 R0 M
Febrile:发热的 ' C* z0 I# \& h- l( B; ~- q
FFP:fresh frozen plasma,新鲜冰冻血浆
. {, ^2 ?1 {- S* ]5 X" P0 w7 p, S" PFGF:fibroblast growth factor,成纤维细胞生长因子
) f% J! P9 x7 f/ N" DFHH:familial hemophagocytic histiocytosis,家族性嗜血组织细胞增生症  f% \, H8 \. X2 ]
FISH:fluorescence in situ hybridization,荧光原位杂交9 }4 h5 ~* m# J! y6 w
FMF:familial Mediteranean fever,家族性地中海热
4 O" Z# Y) }& S, r. c) R% DFoley catheter:弗利氏导尿管,气囊导尿管 2 K: [8 d3 G$ D, C" q1 w
FrTBI:fractional total body irradiation,分次全身照射8 m" ~3 U# d: C  C- c! ?5 ]2 ?4 y9 c
FSRC: 胎羊体内增殖的人造血干细胞
" x4 v$ Z  `2 K3 bFungus:真菌
, ^" E' Z- ^* }: WFungi: Fungus复数形式
( n7 y" E! ^$ E1 p3 L! sG6PD:glucise-6-phosphate dehydrogenase,6-磷酸葡萄糖脱氢酶
8 p: o* W+ l6 P! N' A% aGastritis:胃炎 : c- e. ~3 v, X/ U+ W
Gastrointestinal:胃肠道的
) `" g4 ]9 I$ Y/ a7 K; UG-CFC:granulocyte colony forming cells,粒细胞集落形成细胞6 z$ o& M0 r* R4 F: Z6 V' U. @
G-CSF:granulocyte colony stimulating factor,粒细胞集落刺激因子 : X2 }7 O3 P1 _( A  i8 H/ v
GCV:cytomegalovirus,巨细胞病毒, c& h$ u2 v  A2 E8 Z0 s5 I; o
GCV:ganciclovir,更昔洛韦8 B! k. ~0 X% V' Q
GI:gastrointestinal,胃肠道的& T$ b* K7 `) g
GM-CSF:granulocyte-macrophage colony stimulating factor,粒-巨噬细胞集落刺激因子 & T( v' s" a! G+ l! ^# C  d
GM-CFC:granulocyte-macrophage colony forming cells,粒-巨噬细胞集落形成细胞
/ H  m( c) p7 Q0 a6 W, VGraft rejection:移植排斥(反应)
$ D9 R( F$ h% U, o" Q3 b, ?/ m% G9 N( UGraft-versus-host disease:移植物抗宿主病 8 ?+ M6 u. }$ @7 U0 Y0 g5 B
Granulocyte:粒细胞
( e! t! u4 u1 }* QGrowth factor:生长因子
- A3 C9 I* s+ O& j; K. G& ]GTR:granulocyte turnover rate,粒细胞转换率7 z/ h4 b  R, @) D
GVHD:graft-versus-host disease,移植物抗宿主病 3 Y# z# G/ P5 H* u
GVHR: graft-versus-host reaction,移植物抗宿主反应: b/ e7 F, @/ o( p/ a
GVL:graft-versus-leukemia,移植物抗白血病4 n7 Y0 U/ d% ^  C8 n
GVT:graft-versus-tumor,移植物抗肿瘤2 t% L! q5 ?: U3 C$ _: Q
Haploidentical: 半相和的* |+ M" w* e1 Z  _
Harvest: 收集,采集
' V& d- D& h# x/ ~* jHC:hemorrhagic cystitis,出血性膀胱炎4 H3 `- V/ }' D* r* y+ j6 A
HCL:hairy cell leukemia,毛细胞白血病
2 M& ~$ ^, a" L4 ^+ [# g" [! VHD:Hodgkin's disease,霍奇金病
& O/ y. ]3 B# Q1 @( a* x1 l) yHD:high dose,大剂量! C% R5 D" [2 N
Hematocrit:红细胞压积 ( ?$ }1 A# n1 f' I7 \  a4 m0 Q
Hematology:血液学
) m# H  n/ P/ x( P* {4 MHematopoiesis:造血作用,生血作用! y! n% \) a1 I6 f
Hematopoietic system:造血系统
  ?/ Y! V8 b7 w5 Q3 z9 |, J7 w! \Hemoglobin:血色素,血红蛋白 6 i4 ^0 G$ z) ~# ?1 ?% w
Hemorrhage:出血 / e7 w/ z% ]- u. e
Hemorrhagic cystitis:出血性膀胱炎
, z5 Y0 e+ d$ z* m' S5 r" [( j3 P5 pHepat - :(前缀)肝的6 T& z3 [; ~1 T0 u, R# i
Hepatitis:肝炎 9 c" R; T# ?# J
HES:hypereosinophilic syndrome,高嗜酸粒细胞综合征
2 w7 f$ Y4 V+ R; w! bHGF:hematopoietic growth factor,造血生长因子- @4 @- h2 n* Z2 o, c7 I
HHV:human herpus virus,人疱疹病毒5 _- r: i- V/ i" \5 ]
Hickman catheter:Hichman导管,中心静脉插管 ; Q$ A+ S6 x" v0 X- O
HIV:human immune deficiency virus,人免疫缺陷病毒
# k/ a- H; l5 E/ \# ^HLA:human leukocyte antigen,人类白细胞抗原
' C( x0 k- O4 Q3 `, k+ }HLH:hemophagocytic lymphohistiocytosis,嗜血细胞性淋巴组织细胞增生症
+ e  T0 P8 E# Y# X9 s( Y- _HMR:histiocytic medullary reticulosis,组织细胞性髓性网状细胞增生症
8 I& w, w: n  m# u( ]5 E0 [3 GHomogenic transplantation:同基因移植) L3 S7 m7 X+ E* _7 N# L
Homozygote:纯合子% X, h" z0 K/ C7 C# s
HPC:hematopoietic progenitor cell,造血祖细胞
1 U; Y6 R  c5 d8 g" x  C3 hHPP-CFU:high proliferative potential colony-forming unit,高增殖潜能集落形成单位
( N& W& A; ~* I2 lHR-ALL:high risk ALL,高危型急性淋巴细胞白血病( V0 z/ o% W0 Y! d6 k$ ~% _1 i
HSC:Hand-Schuller-Christian disease,韩-薛-柯病
) p2 F3 ^/ h3 w! e' QHSC:hematopoietic stem cell,造血干细胞7 y: b. B% r% B/ y
HSR:homogenously staining region,均染色区& L8 b0 C4 e' r8 q' U2 X; W8 U$ x
HSV:herpes simplex virus,单纯疱疹病毒
3 G# z! X3 `6 ~7 p% r- EHTC: typing cell,纯合子分型细胞0 b3 q. i+ Y5 w. W! ^; ]3 \! [
HTLV:human T cell leukemia virus,人类T细胞白血病病毒# d; F- ]. g% F% d1 t# L) _  J
HVOD:hepatic venous occlusive disease,肝静脉闭塞病& D1 k5 }% }) P7 C/ ^1 b( r
Hyper- :(前缀)高,超,(过)多
8 G2 q% g6 O8 e) f7 g) NHyperalimentation:高营养支持,静脉高营养* P& h) u2 @7 a' V9 c- L% o! o* f
Hyperpigmentation:色素沉着过度 % @) E# n8 m" X$ E8 p* \
Hypertension:高血压
$ N5 C; `) C# k9 M& a0 iHypo- :(前缀)(过)低,少于. v5 ?) _2 [, C6 C
Hypotension:低血压
" q! J: q& w) c& q3 V$ `IAHS: infectous-associated hemophagocytic syndrome,感染相关嗜血细胞综合征
& l7 }  \5 o; W7 I% l* }9 Mid:medium dose,中剂量4 R- c* E$ R4 J  {& z9 X6 k+ j
id:initial dose,初始剂量1 h- Y' \4 g1 }9 _* a. I* ]
IF:involved field,累及野
" ~$ a. H$ ^$ }9 N! X! rIFN:interferon,干扰素
- m) L& r+ Q2 {1 l' E& X) D4 ?Ig:immunoglobulin,免疫球蛋白 3 N7 O! n/ C5 W
IGFs: insulin-like growth factor,胰岛素样生长因子! ^5 ?: d- ^1 k# b- j$ {
IgH:immunoglobulin heavy chain,免疫球蛋白重链
1 t" ]  J! h6 N! E) B! D; zIL:interleukin,白细胞介素, H7 [+ p* @% v9 c! h
Iliac crest:髂嵴 ( H+ ^1 [/ V9 x; P% T$ {
I.M.:intramuscular,肌肉注射
4 c. @, n6 v0 |  T5 QImmune system:免疫系统
+ a4 h9 f# I# q: h% ?" s; eImmunocompromised:免疫受损的
' }) y" C5 F( J1 A% [9 E, JImmunoglobulin:免疫球蛋白
; C' ~, p# i( E( l$ ]8 oImmunological tolerance:免疫耐受/ _! ?. L3 M4 C
Immunosuppression:免疫抑制
$ t8 z& g6 y& O& A4 jIncubation:孵育& m& W, t. f  S7 _( o) {
informed-consent:知情同意
. j' _  j: t$ Q  q5 Y% W: uIntravenous:静脉内的
8 k9 u+ y; ^. o# s, d1 dinv: inversion,倒位
9 i2 {2 d( Y3 _+ Sin vitro: 体外,离体9 d8 V2 C0 }( ~4 u  {
in vivo: 体内
* G7 T) J# l' i  s% @- MIP:interstitial pneumonia,间质性肺炎, [8 S$ _* M+ o" ?2 M; k% P
Isolation: 分离0 [3 f+ U$ a* l, D
I.T.:intrathecal injection,鞘内注射
. J5 v4 ]: c' j2 t! b6 m! R5 W% e-itis:(后缀)炎症 & _- C: G3 d$ m* u1 R: x  X0 a
ITP:idiopathic thrombocytopenia purpura,特发性血小板减少性紫癜) e# C- w  i. N- K
Jaundice:黄疸) ]4 V' y' T% ^+ l5 J8 f1 G
KPS:Karnofsky score, Karnofsky评分
3 M& O0 v/ L9 ]LAK:lymphokine-activated killer(cells),淋巴因子激活杀伤(细胞)
3 X3 J: x" C( F# uLaminar air flow unit:层流间 9 }% Q( q, S% G
LCH:Langerhans cell histiocytosis,郎格罕细胞(组织细胞)增生症- r+ \  ~4 q5 m$ F
LD:lymphocyte depletion,淋巴细胞消减型
- y7 x& K% k* h+ f0 l4 aLD:low dose,小剂量+ s% [% A4 P/ a
LDH:lactate dehydrogenase,乳酸脱氢酶0 D2 }6 V; y& U2 b4 t
Leukapheresis: 白细胞采集物3 Z( F% {" E$ X8 a0 _
Leukemia:白血病 7 X* l8 O- L, {. Y! h
Leukocyte:白细胞
0 C9 v# w! M1 ]  c' B% t8 p' mLeukopenia: 白细胞减少症
/ D) g5 ?7 u  c$ n% @# L" ^/ hLFA:lymphocyte function associated antigen,淋巴细胞功能相关抗原 / u0 X3 L' I5 }  E" u) Y/ W' E
LFS:leukemia free survival,无白血病存活期
/ j. N' g( g( u2 u! X- D: k8 q; yLGL:low grade lymphoma,低度恶性淋巴瘤0 y. r' u4 L' M, O% f1 B
LHR:lymphocytic homing function receptor, 淋巴细胞归家功能受体
7 \) M; R. a6 N& I7 s, xLI:labeling index,标记指数
* O; {& J- @! J% xLIF:leukemia inhibition factor,白血病抑制因子
3 @' w0 H0 ^) d; l3 YLineage:系
+ o. V5 j% w4 j  LLOH:loss of heterozygosity,杂合性丢失. d9 A* J3 |3 T
LP:lymphocyte predominance,淋巴细胞为主型/ Y( w7 d& {' C8 i0 Y2 T7 ?
LRP:lung resistance related protein,肺抗性相关蛋白; {8 Y- G2 E1 ?3 J2 @0 H
LTB:life-threatening bleeding,致命性出血6 y9 E# t& |- w! q  M& G$ V9 Y2 w9 o
LTC-IC:long-term culture-initiating cell,长期培养起始细胞/ T. L% N2 d* J  `
LTR:long terminal repeat:长末端重复序列
5 G  W! p7 Z# C% ?6 g) V% X, cLVL:large volume leukapheresis,大容量白细胞单采
/ R, [) f1 B2 r- QLymphocyte: 淋巴细胞
6 V' x0 L% i  d/ y7 hMacrophage:巨噬细胞3 }* j# p) o2 E
MACS:magnetic activated cell sorting,磁性活化细胞分选/ m* s3 @' d6 ^9 z2 o3 L+ W
MAK: monocytokine-activated killer(cells),单核细胞因子激活杀伤(细胞)+ I: a# q0 q4 u( t* z6 y
Malabsorption:吸收障碍
6 W) |2 t: R5 M! M. U% u: _' IMALT:mucosa-associated lymphoid tissue,粘膜相关淋巴样组织÷
& n6 `! m) h7 mMatching:配型
7 S+ R4 `+ ]8 D5 |5 {+ k; Y0 wMBDI:marrow blast decline index骨髓原始细胞减少指数- L( G% J- _6 o5 A. }) q' x* d  J! f
MC:mixed cellularity,混合细胞型
3 t# a$ C0 x- R6 a, V) d8 q" V" L/ vMcAb:monoclonal antibody,单克隆抗体' u: Q% o: N7 F+ ]; }6 c
mCR: median complete remission,中位完全缓解 1 Y. G9 B3 U' X4 s
MDR:multiple drug resistance,多药耐药
$ c1 O0 }, g- g! QMDS:myelodysplastic syndrome,骨髓增生异常综合征
, P, j( _) R. ?Megakaryocyte:巨核细胞2 v  a! U- F5 N9 f$ _5 T+ g
Metabolite:代谢物
0 K1 B( _. F* L! s& Y( TMetastatic:转移的 6 R2 a, C1 L$ J; S* Y
MF:myelofibrosis,骨髓纤维化4 M! f3 A8 }- O6 [  y5 h. f
MF:mycosis fungoides,蕈样霉菌病
8 @1 \, i: Y9 X) Q4 o( hMGDS:megakaryocyte growth and differentiation factor,巨核细胞增殖分化因子: x  s& Q: \/ e
MGP:marginal granulocyte pool,边缘粒细胞池
0 a& g& Z. k# k6 l  o  gMGUS: monoclonal gammopathy of undetermined significance,未定性的单克隆γ球蛋白血症( g5 X( I6 w$ d: g% |9 R
MH:malignant histocytosis,恶性组织细胞增生症" b0 U" R6 b) c: p2 D
MHAS:minor histocompatibility antigen systems,次要组织相容性抗原系统
5 S. ?! I8 U$ _1 I$ h  Q- k& n+ W& UMHC:major histocompatibility complex,主要组织相容性抗原复合体
7 C  g  b  J- e9 W, H; l9 \, P: L; U/ }MLC:mixed lymphocyte culture,混合淋巴细胞培养 & s2 \* E8 c' W* D* q
MLL:mixed lineage leukemia,混合系白血病
- f/ @9 |' p. J  S) X: qMM:multiple myeloma,多发性骨髓瘤2 t; o8 y- P: s! r. n0 S0 t
MNC:mononuclear cells,单个核细胞
3 R7 X6 {. P  F# B$ X# C1 EMobilization:动员6 i: V0 d# Q; z! x  A" |
Monoclonal antibody:单克隆抗体 / ~7 Q1 G$ l, T7 B% K5 C
Monocyte:单核细胞
) N0 ~: x% d. W/ Z/ I7 O0 r8 E; S7 ]6 qMonozygotic:单合子的0 {$ g+ ?" z! y# E
Morbidity:发病率
/ E, l# s6 ^5 M) v6 DMPD:myeloproliferative disease, 骨髓增殖性疾病& {: a& M5 D2 G8 N: M. o6 P
MPO:myeloperoxidase,髓过氧化物酶: @+ s1 ~4 l8 c- u) L5 C& n
MRD:minimal residual disease,微小残留病变 . @  V* S0 b" q( W% l
MRP:multidrug resistance-associated protein,多药耐药相关蛋白6 y5 @4 ]+ ^8 D8 D
Mucositis:粘膜炎
- {) T2 c) C+ a5 _; W) W  ?! hMUD:matched unrelated donor,非血缘关系配型相合供体4 y2 C0 }0 O6 z" q6 e! E4 e  ?
NAP:neutrophil alkaline phosphatase,中性粒细胞碱性磷酸酶9 [( {& @+ K$ \$ G7 f9 {# i
NB:neuroblastoma,神经母细胞瘤2 a& N: w6 C5 ~7 P3 m, z
NBM:normal bone marrow,正常骨髓6 v$ y& L' L, W
Negative selection:阴性选择
% j7 f$ Q+ W1 UNeuro- :(前缀)神经的  U* D9 z2 C, V/ H% }. u, [/ Y
Neutropenia:中性粒细胞减少症
0 n9 ~: X( R. v4 v1 }5 u+ QNeutrophil:中性粒细胞 2 @" }, h; ^5 h
NG:neutrophil granulocyte,中性粒细胞
& i! t- ^& J+ m( {NGF:nerve growth factor, 神经生长因子
6 L" y& R% N" Z0 @NHL:non-Hodgkin's lymphoma,非霍奇金淋巴瘤
" a6 d* V- D5 \NK: nature killer cell,自然杀伤细胞8 H' S6 C6 I7 Y- q! f
Nonmyeloablative transplantation: 非清髓性移植
7 C0 d4 @+ m/ I" ?, i. x, n- tNPO:不能进食 " e: W. f$ S" }! `
NS:nodular sclerosis,结节硬化型 3 [6 E& U" [4 D( X
Oncology:肿瘤学
$ a3 X/ |1 r4 pOto- :(前缀)耳的/ E) n; O- _( U( l4 P' ?7 X2 n
PA:plasminogen activator,纤溶酶原激活物; z, a$ y, L4 S/ p6 _
Packed red blood cells: 压积红细胞
& b2 e9 X  K1 l4 h5 ePAE:post antibiotic effects,抗生素后续作用
# ^: v6 K- e- a8 J, r$ Q( m- KPAI:plasminogen activator inhibitor,纤溶酶原激活物抑制剂
2 b) y# W4 {" w: n( |0 J: J) E; f: @$ yPalliative:减轻的,缓解的
, U* K. J+ E' N0 H7 M: cpalliative care unit (PCU):终末期病房,临终关怀病房- v( ^2 D8 t; ^& G' S  k
Pancytopenia:全血细胞减少症
& w" {' I3 ]" l7 X-pathy:(后缀)病
* ~) A+ P0 v, J& s; E/ Q: l- @. |PB:peripheral blood, 外周血
6 N& z3 c& h. O- }; ^  PPBL:peripheral blood lymphocyte,外周血淋巴细胞. p7 m# z; Y9 d+ ]1 L
PBPC:peripheral blood progenitor cell,外周血祖细胞
, q: @' ~' ]* G0 n7 X/ @' ^' I! k) d- gPBSCT:peripheral blood stem cell transplantation,外周血干细胞移植2 X5 P+ ?$ k- ~) q+ `6 x( Z! K9 O* n
PCA:procoagulant activity,促凝活性物质
' \5 z, j/ q$ IPCD:programmed cell death,细胞程序化死亡
5 \  V9 f- w+ B9 oPCL:plasma cell leukemia,浆细胞白血病
9 a0 c9 N' H0 |2 ?0 |4 v, n9 oPCLI:plasma cell label index,浆细胞标记指数# S% t% ^1 K* u& ^5 d5 i
PCR:polymerase chain reaction, 多聚酶链反应
( K2 ~5 |9 F" R; RPCR-RFLP: PCR-restriction fragment length polymorphisms,限制性片段长度多态性分析
$ n5 v: R7 \: j2 M4 s9 H( ]* XPCR-SSOPH: PCR-sequence specific oligonucleotideprobe hybridization,序列特异性寡核苷酸探针杂交% {! t* p6 S+ v) g" G
PDD:percentage depth dosage,百分深度剂量3 F. [5 p; [" j& B* H/ i+ R
PDGF:platelet derived growth factor,血小板衍生生长因子
! p' b3 B7 ^8 d  ~. G! U9 C- e( B; EPDR:primary drug resistance,原药耐药2 I$ {  {7 F6 A; Y; s
PE:plasma exchange,血浆置换
  I: m! y  x3 u' t- R; K-penia:(后缀)缺乏,不足
* `+ g( j0 p( m3 F2 }& G& APeripheral neuropathy:周围神经病变 % x; z6 S+ W# U* h: s- l& P! g
Petechiae:瘀点,瘀斑
$ n6 B/ I1 ?. |1 ePfu: plaque forming unit,空斑形成单位
8 t: c% r/ D) j/ O/ {# NPHA:phytahematoagglutinin,植物血凝素, ~& j' j: }9 V: H; ?. C0 t3 O
Phlebitis:静脉炎
9 z+ l' s. j3 k+ r- O0 _PHSC:pluripotential hematopoietic stem cell,多能造血干细胞
5 g% d- ?8 t, G* z4 S) @5 D-plasia:(后缀)发展,形成
( C  Z  u" n! t% r( aPlasma:血浆- S+ s9 b6 u/ b) k' T. j3 B2 A
Plasma cell: 浆细胞 : H# E' h, h( ^; u
Platelet:血小板 0 I7 a& K9 W, t, c+ ?" }' F
PLG:plasminogen,纤溶酶原4 m2 R% b8 L3 O7 W7 |: d
PLL:prolymphocytic leukemia,幼淋巴细胞白血病. Q+ D( p* f" f- ^4 z* g" ~0 v
PLT:platelet,血小板
9 h# w# B4 y" ~0 {0 F7 F" PPLT:primed lymphocyte test,预致敏淋巴细胞试验* X  ^& U% `. c; ~
PMN:polymorphonuclear leukocyte,多形核白细胞1 R3 }  y; D7 X5 X
PNH:paroxysmal nocturnal hemoglobinuria,阵发性睡眠性血红蛋白尿÷
0 w6 W8 [* f& j: j- T1 ], BPNRE:p53 negative response element,p53阴性反应元件2 \- q5 e6 y6 ^
POD:PML oncogenic domain,PML癌基因结构域
: y( F8 \4 m2 U" ^  }% G' vPolycythemia:红细胞增多症
/ |) K( h# G# q5 v1 J7 v( S5 bPositive selection:阳性选择
0 {6 |3 i- o! a7 SPPSC: pluripotent hemotopoietic stem cell,全能造血干细胞9 p9 r0 a' H" P, R
Preparative regimen:预处理方案 , F2 ?, W- `' T3 `/ i
Progenitor:前体,祖先
' e0 C; z" @: W2 Q! ]8 |; tPrognosis:预后 1 w8 m) y3 F3 N! O( W
Prophylactic:adj.预防的;n. 预防性,预防药: F" h6 k* S$ Z, }4 V. V, q
Prophylaxis:预防法,预防4 s8 F( v+ X' _
Protocol:草案,协议,治疗方案 7 B/ d' H# m% I6 }' P
Proto-onc: proto-oncogene,原癌基因
. ]& t  V' i. R% OPSS:posterior superior spine,髂后上棘, Q9 a2 g; _/ m+ k" }% d
PT:prothrombin time,凝血酶原时间
: H4 c( A1 @. w: W$ fPTCL:peripheral T celll lymphoma,外周T细胞型淋巴瘤$ ~: N/ Y' s9 E2 K- q- b7 O: A
PTH:post-transfusion hepatitis, 输血后肝炎
9 Y9 s, e; |  K5 S; D3 _9 ~+ n, v) rPulmonary:肺的
" s  H$ G6 f: Z& D6 t8 XPurging:净化/ {8 r* U, f) B# o  Q
Purity:纯度0 r/ Y  I. \8 K, n8 {' K
PV:polycythemia vera,真性红细胞增多症
2 N7 S' p" O4 k7 F7 N5 i! @& FQuality of Life (QOL):生活质量6 R4 }* a4 I- \0 H! m5 V+ h0 m" L
RA:refractory anemia,难治性贫血 ! @+ ^- _( `# V3 ?
RAEB:refractory anemia with excessive blasts,难治性贫血伴原始细胞增多型
: F+ P6 U/ `" F6 @7 V( Y/ jRAEB-T:refractory anemia with excessive blasts,transformation,难治性贫血伴原始细胞增多转化型. a8 X8 H! n" ~
RAR:retinoic acid receptor,维甲酸受体9 T/ I! G" q" Y; `, j2 ^3 M* G
RAS:refractory anemia with sideroblasts,难治性贫血伴环状铁粒幼细胞增多
) U# N; `) Y6 `RAS:retinoic acid syndrome,维甲酸综合征! ]" D2 O' j5 ^: {* v
RB:retinoblastoma,视网膜母细胞瘤
) }/ M" u& g" |# z# I5 V% z) d' A! uRBC: red blood cell,红细胞 6 q' ^# \4 z# F2 `" [5 o# N* C
Reagent:试剂1 B5 H- b1 C1 K4 r& i6 t4 p
Recipient:受者
+ o3 g/ _' [/ m4 K5 p. o3 U2 Q; nRejection:排斥5 B5 {/ i* Z" E. N7 d. L% q, w
Relapse:复发 ' n( `3 k# \0 |9 Z0 G" y  O
Remission:缓解
' r, _2 j2 ^2 g# |7 J- bRenal:肾脏的,肾的 ) Y% b5 Z6 O. |6 [4 {
RFS:replase free survival,无复发生存
. L) R6 k' e" R" P" h2 c9 ~RPC:radiation protective competence, 辐射保护能力
* M9 a( i$ R# w3 T% ]Regimen-related toxicity (RRT):预处理相关毒性
8 R# s! ?7 U9 {7 kRT-PCR:reverse transcription polymerase chain reaction, 逆转录多聚酶链反应& |0 J! ?5 W* t$ S# C+ S# S, n1 H& U# X
SBB:sudan black B,苏丹黑B& ?2 @4 y, t0 M
SCE:sister chromatial exchange,姐妹染色单体交换" Q3 p2 I, [- K- W1 L" D! J9 I
SCF:stem cell factor,干细胞因子! P1 z% @! U2 M0 U; r7 b: ]
SCid:severe combined immunodeficiency disease,重症联合免疫缺陷4 G4 I- G- W) u$ r+ s
SCL:stem cell leukemia,干细胞白血病
7 r. U% O  x9 nSE:specific estarase,特异性酯酶
* z( M- C; _1 B; O' b. @6 FSelectin:选择素
) d. t; Y' R3 a9 U1 m0 ^Sense primer:同义引物& ^5 h; ?+ T1 B7 v
Separation:(细胞)分选
, A- C' l3 x  w0 N% G5 DSepsis:脓血病,败血病 0 G! o9 }' R" `) y, p! X; P
Sequencing测序
8 W- a. o$ D" e# h! j, W- `SF:serum ferritin,血清铁蛋白
* P# p3 a5 r7 `/ O6 U1 k8 fSHML:sinus histocytosis with massive lymphadenopathy,窦性组织细胞增生症伴块状淋巴结肿大: {, B' R0 }9 Z/ o7 v/ N1 `
SIA:stroma-support immunocytometric assay,基质支持免疫细胞流式细胞仪技术法3 v- Q2 s4 u# W9 {2 C  h% ?
SLE:systemic lupus erythematosus,系统性红斑狼疮% i/ l  \/ p; a5 I
SLL:small lymphocytic lymphoma,小淋巴细胞淋巴瘤
5 D6 t. n) W; P' r6 L( b) ySolid tumor:实体瘤
; m! S( D$ x5 q6 \SR-ALL:standard risk acute lymphocytic leukemia,标危型急性淋巴细胞白血病
* K+ \' w! X! a& Y3 b& _1 a+ ISRC:SCid/NOD小鼠体内增殖的人造血干细胞,SCid造血重建细胞" H9 D% j. n/ S# Z( r
SS:Sezary syndrome,Sezary综合征
: F" s2 @3 _5 p- k, p2 S/ jStem cell:干细胞
! p  M  G) {- ASTNI:subtotal nodal irradiation,次全淋巴结照射
+ c( m% d& E5 |Stomatitis:口炎 + ?0 y6 p5 ~  Z4 r0 R
Subclavian catheter:锁骨下导管
& H/ D2 a$ I( c/ u0 N- ?/ ESupernatant:上清3 i. v6 [' E( L- ?( @
Syn-BMT:Syngeneic bone marrow transplant:同基因骨髓移植 / O7 Y" D  s- I8 Z
Syngeneic:同基因的
8 F& Q. }0 j* [: dTAM:tumor associated macrophage,肿瘤相关巨噬细胞
; p; F7 p3 W7 a4 Vt-AML:treatment associated AML,治疗相关的急性髓性白血病
8 x! F% n( y* N! L" GTA-GVHD:transfusion associated graft-versus-host disease,输血相关的移植物抗宿主病; s  w* g! a* C& V! K& c
TAA:tumor associated antigen,肿瘤相关抗原- ~1 a8 C  e$ ^: {1 V, F
TBGP:total blood granulocyte pool,总血液粒细胞池
8 T  i" l5 N: g; q' e  aTBI:total body irradiation,全身照射0 \- `/ _9 V# U' F, H
Tc:time of cell cycle, 细胞周期时间! B) Z( h* ]6 q" |" R$ N, j; \
TCD:T cell depletion, T细胞去除# M- L/ P% t1 H; c  D5 K
TCL:T cell leukemia/lymphoma,T细胞白血病/淋巴瘤   w$ {3 s0 A+ Z/ K
TCR:T cell receptor,T细胞受体( z7 f8 h3 s. y+ ?
TCS:tumor cell survival,肿瘤细胞成活
' T% x" ?9 D) t- e. dTEN:total enteral nutrition,完全胃肠内营养
. _/ d+ U1 \( z1 J' J% C2 YTF:tissue factor,组织因子
$ X, x# _5 t0 m% U+ nTF:thymic factor,胸腺因子) H0 F1 n4 g. p0 S* T+ K1 l2 A3 r* \
TFPI:tissue factor pathway inhibitor,组织因子途径抑制物
% N1 q& ~( v+ L2 pTGF:therapeutic gain factor,治疗获得系数
& I4 ~, k  z# i9 |8 t! _1 NTGF-β:transforming growth factor-β,转化生长因子β
5 q1 W* g, e. eThrombocyte:血小板 , U7 e' Q. O5 W0 s- ]
Thrombocytopenia:血小板减少症. D2 I' K/ A0 y$ b9 T
TIL:tumor infiltrate lymphocyte,肿瘤浸润淋巴细胞
! ~5 a2 e# m- }8 D4 p% S, f, P, STL:testis leukemia睾丸白血病. x; a: x+ m( h& H7 y% {
TLI:total Lymphoid irradiation,全淋巴照射
% o3 y2 b. q: j' x! q  `) x2 T, FThrombotic microangiopathy (TMA):血栓性微血管病' U  D! b3 t9 j& U
TNF:tumor necrosis factor,肿瘤坏死因子" n) o- s3 y! c8 U. g0 M4 i9 t$ Z
TNI:total nodal irradiation,全淋巴结照射
; }- r8 N& ^1 k) J9 }% cTOPO II:topoisomerase II,拓扑易构酶II
; Y' H1 w. q; F' dToxin:毒素   H3 o/ U% P1 {+ o" F( a
Tpdt:potential doubling time,倍增时间+ E1 E% b0 A$ S) a; c8 w, Y4 E
T-PLL:T-prolymphocytic leukemia,T幼淋细胞白血病
5 U* ?: o. z! RTPN:total parenteral nutrition,全肠道外营养,静脉高营养
8 q9 [$ r* k5 R( J1 hTPO:thrombopoietin,促血小板生成素% A2 G  @7 w  Y: G9 G
TPS:treatment planning system,治疗计划系统
) V2 v1 L) B8 h, p8 y2 STranslocation:易位
4 |2 ]; x* E" j+ D. e+ ?9 v, vTrauma:创伤
+ N3 X' a  H$ A& r3 qTRM:transplantation related mortality,移植相关死亡率
. w) ^# d! M. x( ]$ \0 u5 u, YTSC:timed-sequential chemotherapy,时相序贯化疗* Y8 g2 Z5 V+ l& s
TSPA:triophosphoramide,噻替派
" M" m1 r) g. a$ t- {) b* S  aTTP:thrombotic thrombocytopenic purpura,血栓性血小板减少性紫癜! g3 x% d! [7 u9 E& b
Tumor:肿瘤
; B# l' v" }- _6 wTumor burden:肿瘤负荷 + s' Y0 F3 x5 I1 M1 H
UCB:umbilical cord blood,脐带血
, H" g" ~- F! o% m# CUltrasound:超声
0 O. W. D5 H- L& `( E% UUmbilical cord:脐带1 _6 T8 o  q5 @2 d
VAHS:viral associated hemophagocytic syndrome,病毒相关嗜血细胞综合征
2 ~  u" S  ~6 P9 B( ZVGPR:very good partial remission,非常良好的部分缓解
) t' E3 w' V) g. dViability:活性
3 z- _! c# r0 b3 aVirus:病毒
$ j9 c: J3 I3 L1 kVOD:veno-occlusive disease,静脉阻塞性疾病
$ j2 \0 m" I4 ?0 Z. S5 zv-onc: virus oncogene,病毒癌基因
9 X; s" I' z- k' K* mVPF: vascular permeability factor,血管渗透因子% N2 S5 q+ V# G: l5 d+ W
VZV:varicella zoster virus,水痘带状疱疹病毒
( j3 ?% z: }- r& w- H; R! kWBC:white blood cell,白细胞
/ c( ?: E2 M. u' I7 HWhole blood:全血
& B* z7 m: f8 N+ G1 Q: a' ~# w. PWT:Wilms tumor,肾母细胞瘤5 ^9 l: d5 f  c! O! A
Xerostomia:口腔干燥症 5 A. U9 k" i$ t: W! [& J6 v
Yield:产量
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2026-2-20 09:37

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.